Dec 13, 2022
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced the appointment of Marc Malandro, Ph.D., to the company’s scientific advisory board. Dr. Malandro, a highly regarded scientific leader and expert in genomics, molecular biology, biochemistry and bioengineering, will serve alongside other key thought leaders in their respective fields to guide the company’s initiatives and growth strategy. “Marc is not only a very insightful scientist, but he is an equally perceptive and thoughtful innovator. His understanding of the business of science, and the commercial application of novel discovery, is precisely why he is such a valuable scientific advisor,” said Predictive Oncology’s CEO and Board Chairman Raymond F. Vennare. “Marc’s understanding of the depth and breadth of the biopharmaceutical industry is invaluable as we look to build relationships and progress to help accelerate drug discovery and advance drug development.”
To view the full press release, visit https://ibn.fm/Jje9E
About Predictive Oncology Inc.
Predictive Oncology is a knowledge-driven company focused on applying artificial intelligence (“AI”) to develop optimal cancer therapies, which can lead to more effective treatments and improved patient outcomes. Through AI, Predictive Oncology uses a biobank of 150,000+ cancer tumors, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of success. The company offers a suite of solutions for oncology drug development from early discovery to clinical trials. For more information, visit the company’s website at www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork
As Ukraine increasingly takes the war to Russia, the effects may be most visible on the roads.
China has called on G20 members to uphold multilateralism and strengthen cooperation, as trade ministers met in Milwaukee, USA, from September 30 to October 1 to discuss food security, industrial overcapacity, forced labor and the most-favored-nation principle.
Rising prices, weak spending put Japan's policymakers in tight spot
China's Ministry of Commerce said on Sunday that China played a constructive role at the G20 trade ministers' meeting, held in Milwaukee, the United States, from September 30 to October 1.
The film, starring Tom Cruise, grossed an estimated $8 million in its opening weekend. That could put the movie on track to lose at least $125 million.
Faced with bots immune to traditional marketing tactics, marketers are racing to win them over with logic and data.
China has started limiting exports of refined products again as its own inventories of crude oil and refined products have dwindled.
Fewer orders and higher costs are squeezing restaurants big and small as people on the weight-loss drugs eat and drink less when dining out.
The fiscal 2026 earnings cycle has underscored the extraordinary momentum behind the AI boom, with tech giants posting record revenues while their shares have also rallied. But beneath the headline numbers, a new test is emerging: how long can AI-driven cash generation keep pace with the massive investment required to expand computing capacity?
The president, who had hoped to tout a growing economy on the campaign trail, has found it hard to break through as workers’ wages fail to keep up.
Immediate action is needed to help households struggling with bills this winter, says trade body Energy UK.
Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.